Precision Retrospective Integrative Study for Metastatic Lymph Nodes in Breast Cancer

Launched by CENTRO DI RIFERIMENTO ONCOLOGICO - AVIANO · Dec 12, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on improving how doctors assess lymph nodes in patients with breast cancer. Lymph nodes are small glands that can indicate whether cancer has spread. The study aims to use a new method that combines various types of data, including MRI images and clinical information, to more accurately detect cancer in lymph nodes. This could help in planning better treatment and understanding how the disease responds to therapy over time.

To participate in the trial, patients need to have been diagnosed with breast cancer and have had an MRI along with a biopsy or surgery on their lymph nodes. The study welcomes individuals of all genders and ages, specifically those in stages I to III of breast cancer. Participants can expect to contribute to important research that could improve the accuracy of lymph node assessments, which is crucial for their treatment journey. However, patients who have had previous breast cancer or certain types of surgeries may not be eligible for this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients diagnosed with breast cancer who underwent MRI and biopsy or surgery of axillary lymph nodes as part of their diagnosis and treatment
• • Patients of all genders, ages, and stage I-III of breast cancer
• • Patients who underwent neoadjuvant therapy and have longitudinal imaging data available for analysis (for secondary outcome analysis)
• Exclusion Criteria:
• • Patients whose MRI images were of insufficient quality for analysis
• • Patients who had a previous history of breast cancer
• • Patients with a history of axillary surgery or lymph node dissection prior to the current diagnosis of breast cancer
• • Patients who received neoadjuvant therapy at another institution